Market revenue in 2023 | USD 1,029.6 million |
Market revenue in 2030 | USD 2,721.4 million |
Growth rate | 14.9% (CAGR from 2023 to 2030) |
Largest segment | Spinal cord stimulator |
Fastest growing segment | Sacral Nerve Stimulator |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator |
Key market players worldwide | Medtronic PLC, LivaNova PLC, Boston Scientific Corp, St. Jude Medical, Nevro Corp |
Spinal cord stimulator was the largest segment with a revenue share of 50.01% in 2023. Horizon Databook has segmented the Asia Pacific neurostimulation devices market based on spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, gastric electric stimulator covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific neurostimulation market is expected to grow considerably owing to availability of lucrative growth opportunities in this region, especially in China, India, and Japan. Mandatory healthcare insurance, technological advancements, and increased healthcare expenditure are driving the neurostimulation market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account